Revenue Recognition - Disaggregation of Revenue (Details) - Product Concentration Risk - Revenue from Contract with Customer Benchmark	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pharma and biotech
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	30.00%	22.00%	8.00%
Agriculture
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	24.00%	8.00%	8.00%
Industrial and environment
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	16.00%	12.00%	16.00%
Food and nutrition
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	16.00%	9.00%	25.00%
Consumer and technology
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	8.00%	45.00%	36.00%
Government and defense
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	6.00%	4.00%	7.00%
Total Cell Engineering revenue
Disaggregation Of Revenue [Line Items]
Concentration risk percentage	100.00%	100.00%	100.00%